2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $13B | $14B | $16B | $16B | $16B |
Cost of Revenue | $7.4B | $8.5B | $9.4B | $9.3B | $8.9B |
Gross Profit | $5.2B | $6B | $6.5B | $6.8B | $7B |
Gross Profit % | 41% | 41% | 41% | 42% | 44% |
R&D Expenses | $2.2B | $2.4B | $2.6B | $284M | $2.7B |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $2.1B | $2.7B | $3B | $3B | $3.5B |
Dep. & Amort. | $427M | $410M | $410M | $395M | $402M |
Def. Tax | -$30M | -$148M | -$150M | -$88M | -$176M |
Stock Comp. | $42M | $53M | $63M | $69M | $61M |
Chg. in WC | $249M | -$438M | -$816M | $210M | -$18M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $2.6B | $1.5B | $708M | $1.1B | $948M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $2.6B | $1.5B | $708M | $1.1B | $948M |
Receivables | $0 | $0 | $0 | $3.3B | $0 |
Inventory | $1.2B | $1.7B | $2.1B | $1.7B | $1.6B |
ITW delivered a strong Q4 2024 performance, achieving record operating margins of 26.2% and GAAP EPS of $2.54, despite a 1.3% decline in total revenues. Organic revenue was down 0.5%, but excluding product line simplification (PLS), it grew by 0.4%.
For 2025, ITW projects organic growth of 1% to 3% (excluding PLS) and GAAP EPS in the range of $10.15 to $10.55, with a midpoint reflecting a 5% increase excluding foreign currency headwinds. Operating margins are expected to improve by 100 basis points to a range of 26.5% to 27.5%.
The company highlighted strong contributions from enterprise initiatives, which are expected to drive margin improvements across all segments in 2025, with Automotive OEM and Specialty Products showing significant potential for further gains.
ITW continues to focus on customer-back innovation (CBI), with patent filings increasing by 18% in 2024. The company aims to achieve a CBI yield of 3%+ by 2030, supported by its new CBI framework and ongoing investments in innovation.
ITW plans to repurchase $1.5 billion of its own shares in 2025, reflecting its strong financial position and disciplined capital allocation strategy. The company remains well-positioned to manage potential tariff impacts and capitalize on any recovery in demand across its end markets.